Abstract | BACKGROUND AND PURPOSE: EXPERIMENTAL APPROACH: To measure the effects of statins on MDC expression in HaCaT cells, we used a cell viability assay, reverse transcription-polymerase chain reaction, enzyme-linked immunosorbent assay and Western blotting analyses. KEY RESULTS: CONCLUSIONS AND IMPLICATIONS:
|
Authors | Xu-Feng Qi, Dong-Heui Kim, Yang-Suk Yoon, Jian-Hong Li, Dan Jin, Yung-Chien Teng, Soo-Ki Kim, Kyu-Jae Lee |
Journal | British journal of pharmacology
(Br J Pharmacol)
Vol. 157
Issue 8
Pg. 1441-50
(Aug 2009)
ISSN: 1476-5381 [Electronic] England |
PMID | 19594754
(Publication Type: Journal Article)
|
Chemical References |
- Chemokine CCL22
- Fatty Acids, Monounsaturated
- Heptanoic Acids
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Indoles
- NF-kappa B
- Pyrroles
- Fluvastatin
- Interferon-gamma
- Atorvastatin
- Simvastatin
- p38 Mitogen-Activated Protein Kinases
|
Topics |
- Atorvastatin
- Cell Line
- Chemokine CCL22
(antagonists & inhibitors, biosynthesis)
- Fatty Acids, Monounsaturated
(pharmacology)
- Fluvastatin
- Heptanoic Acids
(pharmacology)
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
(pharmacology)
- Indoles
(pharmacology)
- Interferon-gamma
(pharmacology)
- Keratinocytes
(metabolism)
- NF-kappa B
(agonists, metabolism)
- Pyrroles
(pharmacology)
- Signal Transduction
- Simvastatin
(pharmacology)
- Th2 Cells
(metabolism)
- p38 Mitogen-Activated Protein Kinases
(antagonists & inhibitors, metabolism)
|